2-acetylaminofluorene has been researched along with Cancer of Salivary Gland in 3 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
HEIMAN, J | 1 |
MEISEL, D | 1 |
Reuber, MD | 1 |
Cesarone, CF | 1 |
Scarabelli, L | 1 |
Orunesu, M | 1 |
3 other studies available for 2-acetylaminofluorene and Cancer of Salivary Gland
Article | Year |
---|---|
Tumors of the salivary and parathyroid glands in rats fed with 2-acetylaminofluorene.
Topics: 2-Acetylaminofluorene; Animals; Fluorenes; Neoplasms; Neoplasms, Experimental; Parathyroid Glands; P | 1946 |
Carcinoma and cirrhosis of the liver in A X C male rats with one kidney ingesting 0.025% N-2-fluorenyldiacetamide.
Topics: 2-Acetylaminofluorene; Animals; Carcinoma; Carcinosarcoma; Diet; Fluorenes; Kidney; Liver Cirrhosis, | 1975 |
Effect of glutathione and N-acetylcysteine on hepatocellular modifications induced by 2-acetylaminofluorene.
Topics: 2-Acetylaminofluorene; Acetylcysteine; Animals; DNA; Drug Interactions; gamma-Glutamyltransferase; G | 1986 |